U.S. Food And Drug Administration Clears Vermillion's OVA1(TM) Test To Determine Likelihood Of Ovarian Cancer In Women With Pelvic Mass

The U.S. Food and Drug Administration (FDA) cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass.